The Global Vaccine Research Market is anticipated to rise by USD 21.4 billion, growing at a CAGR of 10.84% from 2023 to 2028, according to Technavio. One of the major drivers behind this growth is the ongoing research into innovative adjuvants and improved vaccine delivery technologies aimed at increasing vaccine stability and efficacy. Adjuvants, essential components added to vaccines, play a crucial role in enhancing the immune system's response. Researchers are exploring new adjuvants and targeted delivery mechanisms to boost this immune response and improve vaccine outcomes. Vaccine manufacturers are focusing on developing formulations for pneumococcal vaccines, Diphtheria-Tetanus, HPV, MMR, Rotavirus, Influenza, Hepatitis B, Chickenpox, Polio, BCG, and Yellow Fever.

Click here to download Vaccine Research Market Sample PDF Click here to Contact us for more Information